Literature DB >> 14535956

15-deoxy-delta12,14-prostaglandin J2 regulates the functional state and the survival of microglial cells through multiple molecular mechanisms.

Antonietta Bernardo1, Maria Antonietta Ajmone-Cat, Giulio Levi, Luisa Minghetti.   

Abstract

We have previously reported that rat primary microglial cultures express the nuclear receptor peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and that several functions associated with the activation of these cells, including nitric oxide (NO) and tumor necrosis factor-alpha synthesis, are down-regulated by 15-deoxy-delta12,14-prostaglandin J2 (15d-PGJ2) and ciglitazone, two specific PPAR-gamma agonists. Here we demonstrate that microglial cells not only express a functionally active PPAR-gamma, but also synthesize large amounts of 15d-PGJ2 upon stimulation with lipopolysaccharide (LPS). In addition, we show that, although 15d-PGJ2 and ciglitazone were equally effective in reducing microglial activation when used at 1-5 microm concentrations, 15d-PGJ2, but not of ciglitazone, reduced PGE2 production at low concentration (0.1 microm) and induced a time-dependent microglial impairment and apoptosis at high concentration (10 microm). Interestingly, the inhibition of PGE2 production was achieved mainly through the inhibition of cycloxygenase-2 enzymatic activity, as the expression of this enzyme and that of the microsomal isoform of PGE synthase remained unaltered. These findings suggest that 15d-PGJ2 affects the functional state and the survival of activated microglia through mechanisms only in part dependent on PPAR-gamma and that the concentration of 15d-PGJ2 is crucial in determining the particular microglial function affected.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14535956     DOI: 10.1046/j.1471-4159.2003.02045.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  13 in total

Review 1.  Microglial activation in stroke: therapeutic targets.

Authors:  Midori A Yenari; Tiina M Kauppinen; Raymond A Swanson
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

2.  Cyclopentenone prostaglandins PGA2 and 15-deoxy-delta12,14 PGJ2 suppress activation of murine microglia and astrocytes: implications for multiple sclerosis.

Authors:  Paul D Storer; Jihong Xu; Janet A Chavis; Paul D Drew
Journal:  J Neurosci Res       Date:  2005-04-01       Impact factor: 4.164

Review 3.  Hormone regulation of microglial cell activation: relevance to multiple sclerosis.

Authors:  Paul D Drew; Paul D Storer; Jihong Xu; Janet A Chavis
Journal:  Brain Res Brain Res Rev       Date:  2005-01-19

4.  PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors.

Authors:  Elisabetta Benedetti; Renato Galzio; Barbara D'Angelo; Maria Paola Cerù; Annamaria Cimini
Journal:  PPAR Res       Date:  2010-03-17       Impact factor: 4.964

5.  Subchronic infusion of the product of inflammation prostaglandin J2 models sporadic Parkinson's disease in mice.

Authors:  Sha-Ron Pierre; Marijke A M Lemmens; Maria E Figueiredo-Pereira
Journal:  J Neuroinflammation       Date:  2009-07-25       Impact factor: 8.322

6.  S. aureus-dependent microglial activation is selectively attenuated by the cyclopentenone prostaglandin 15-deoxy-Delta12,14- prostaglandin J2 (15d-PGJ2).

Authors:  Tammy Kielian; Meredith McMahon; Edward D Bearden; Aaron C Baldwin; Paul D Drew; Nilufer Esen
Journal:  J Neurochem       Date:  2004-09       Impact factor: 5.372

Review 7.  Prostaglandin J2: a potential target for halting inflammation-induced neurodegeneration.

Authors:  Maria E Figueiredo-Pereira; Chuhyon Corwin; John Babich
Journal:  Ann N Y Acad Sci       Date:  2016-01-08       Impact factor: 5.691

Review 8.  Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration.

Authors:  Maria E Figueiredo-Pereira; Patricia Rockwell; Thomas Schmidt-Glenewinkel; Peter Serrano
Journal:  Front Mol Neurosci       Date:  2015-01-13       Impact factor: 5.639

9.  15d-PGJ2 induces apoptosis of mouse oligodendrocyte precursor cells.

Authors:  Zhongmin Xiang; Tong Lin; Steven A Reeves
Journal:  J Neuroinflammation       Date:  2007-07-16       Impact factor: 8.322

10.  Regulation of Glial Cell Functions by PPAR-gamma Natural and Synthetic Agonists.

Authors:  Antonietta Bernardo; Luisa Minghetti
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.